The National Cancer Institute seeks applications to establish a management and data coordination unit supporting collaborative research on early pancreatic cancer detection and precursor lesions.
Funder: National Institutes of Health
Due Dates: January 25, 2027 (Applications) | May 25, 2027 (Applications)
Funding Amounts: Up to $500,000 in direct costs per year for 5 years; one award anticipated
Summary: Supports the management, statistical support, data coordination, and biorepository coordination unit for the Pancreatic Cancer Detection Consortium.
Key Information: Contact and multiple PDs/PIs cannot also serve in those roles on a companion PCDC U01 application or funded Research Unit.
The National Cancer Institute (NCI) seeks to establish the Management and Data Coordination Unit (MDCU), one of two scientific components of the Pancreatic Cancer Detection Consortium (PCDC). The consortium advances early detection of pancreatic ductal adenocarcinoma and characterization of precursor lesions to identify patients at high risk of progression to cancer.
The MDCU will support consortium-wide study design, protocol development, statistical analysis, data management, and collaborative research coordination. Its responsibilities include supporting longitudinal cohorts and biorepositories, coordinating biospecimen transfers to the NCI at Frederick Central Repository, and providing organizational and logistical support. The consortium’s work includes screening markers from liquid biopsies and integration with imaging approaches in high-risk populations. This U24 cooperative agreement involves substantial NCI scientific and programmatic participation and does not allow clinical trials.